Jonathan P. Caulkins

Carnegie Mellon University — United States

Medicine · Health Sciences

55h-index10.6kcitations481works13.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Substance Abuse Treatment and Outcomes(131), Crime, Illicit Activities, and Governance(91), HIV, Drug Use, Sexual Risk(89), Cannabis and Cannabinoid Research(84), Opioid Use Disorder Treatment(76)

Publications481 total

Did the illicit fentanyl trade experience a supply shock?
Science·2026· 2 cited
HEALing communities study results, questions and implications
Addiction·2025Open Access
Possible effects of cheap fentanyl on drug markets, use, and harm: A theoretical analysis
Global Crime·2025
Historical and contextual variation in daily opioid consumption rates: implications for supply control, service delivery, and research
The American Journal of Drug and Alcohol Abuse·2025· 1 cited
Improving Opioid Use Estimates Through Multiple Data Sources
JAMA Health Forum·2025· 1 citedOpen Access
Improving Estimates of the Prevalence of Opioid Use Disorder in the United States: Revising Keyes et al
Journal of Addiction Medicine·2024· 6 cited
Changes in self‐reported cannabis use in the United States from 1979 to 2022
Addiction·2024· 101 citedOpen Access
Riding the waves from epidemic to endemic: Viral mutations, immunological change and policy responses
Theoretical Population Biology·2024· 1 citedOpen Access
The Baltic and Nordic responses to the first Taliban poppy ban: Implications for Europe & synthetic opioids today
International Journal of Drug Policy·2024· 10 citedOpen Access
A detailed study of a prominent dark web fentanyl trafficking organization
Global Crime·2023· 2 citedOpen Access
Modeling cartel size to inform violence reduction in Mexico
Science·2023· 1 cited
Changing dynamics of drug overdoses in the United Kingdom: An attempt to replicate the Jalal et al. findings of steady exponential growth
International Journal of Drug Policy·2023· 1 citedOpen Access
When prohibition works: Comparing fireworks and cannabis regulations, markets, and harms
International Journal of Drug Policy·2023· 1 citedOpen Access
The hammer and the jab: Are COVID-19 lockdowns and vaccinations complements or substitutes?
European Journal of Operational Research·2023· 11 citedOpen Access
The virtues of bans on high‐THC content cannabis products?
Addiction·2023· 3 citedOpen Access
America's Opioid Ecosystem: How Leveraging System Interactions Can Help Curb Addiction, Overdose, and Other Harms
RAND Corporation eBooks·2023· 18 citedOpen Access
The Ecosystem Approach to Opioid Policy
RAND Corporation eBooks·2023
How much illegally manufactured fentanyl could the U.S. be consuming?
The American Journal of Drug and Alcohol Abuse·2022· 10 cited
Rating the comparative efficacy of state-level cannabis policies on recreational cannabis markets in the United States
International Journal of Drug Policy·2022· 12 citedOpen Access
The iCannTookit: a consensus‐based, flexible framework for measuring contemporary cannabis use
Addiction·2022· 2 citedOpen Access
page 1 of 25Next →

Frequent Co-authors

Peter Reuter(14), Beau Kilmer(12), Rosalie Liccardo Pacula(10), Greg Midgette(6), Gustav Feichtinger(6), Gernot Tragler(5), Doris A. Behrens(4), Robert J. MacCoun(4), James Chiesa(4), Dieter Graß(3), John Strang(3), Thomas F. Babor(3), Benedikt Fischer(3), David Foxcroft(3), Keith Humphreys(3), C. Peter Rydell(3), Susan S. Sohler Everingham(3), Wayne Hall(2), Isidore Obot(2), Jürgen Rehm(2)